SCHEMBL15536002

SCHEMBL15536002

O=C(O)N1CCC(C(O)c2ccc(Cl)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 2/20 0.47
PROKR1 Q8TCW9 2/20 0.47
MAPT P10636 1/20 0.44
ENPP2 Q13822 2/20 0.44
RPS6KB1 P23443 1/20 0.42
OPRD1 P41143 1/20 0.41
CYP2D6 P10635 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
CACNA2D1 P54289 1/20 0.41
CACNA1B Q00975 1/20 0.41
CACNB1 Q02641 1/20 0.41
CACNA1C Q13936 1/20 0.41
MGLL Q99685 3/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072569 0.86 OPRD1 (0.46) MAPTRPS6KB1OPRD1CACNA2D1CACNA1B
SCHEMBL4566750 0.85 HTR2A (0.55) CYP2D6KDM4ECYP1A2CYP3A4TSHR
SCHEMBL14335923 0.84 CCR5 (0.51) CYP2D6KDM4ECYP1A2CYP3A4TSHR
SCHEMBL6229667 0.84 HTR2A (0.56) RPS6KB1CYP2D6KDM4ECYP1A2CYP3A4
SCHEMBL27674158 0.84 HSD17B2 (0.41) FPR2PROKR1MAPTCACNA2D1CACNA1B
SCHEMBL29055984 0.81 FPR2 (0.45) FPR2PROKR1ENPP2RPS6KB1CYP2D6
SCHEMBL15535932 0.81 TP53 (0.44) MAPTCYP3A4TSHR
SCHEMBL15537475 0.80 SLC6A4 (0.52) FPR2PROKR1MAPTOPRD1CACNA2D1
SCHEMBL15536288 0.80 FPR2 (0.49) FPR2PROKR1MAPTOPRD1CACNA2D1
SCHEMBL2520399 0.79 ALDH1A1 (0.55) MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104520292-B Sulphonylpiperidine derivant and they are for treating the purposes of disease of front dynein mediation 武田药品工业株式会社 2016-09-14 CN disclosed
EP-2855449-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed
WO-2013179024-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-12-05 WO disclosed